Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DIVIS LABORATORIES ALKEM LABORATORIES/
DIVIS LABORATORIES
 
P/E (TTM) x 25.0 60.4 41.3% View Chart
P/BV x 6.0 13.9 43.3% View Chart
Dividend Yield % 0.8 0.4 183.4%  

Financials

 ALKEM LABORATORIES   DIVIS LABORATORIES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
DIVIS LABORATORIES
Mar-19
ALKEM LABORATORIES/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2,7201,639 165.9%   
Low Rs1,6601,115 148.9%   
Sales per share (Unadj.) Rs697.9186.3 374.5%  
Earnings per share (Unadj.) Rs96.151.0 188.6%  
Cash flow per share (Unadj.) Rs117.357.3 204.6%  
Dividends per share (Unadj.) Rs25.0016.00 156.3%  
Dividend yield (eoy) %1.11.2 98.2%  
Book value per share (Unadj.) Rs515.2261.8 196.8%  
Shares outstanding (eoy) m119.57265.47 45.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.17.4 42.5%   
Avg P/E ratio x22.827.0 84.3%  
P/CF ratio (eoy) x18.724.0 77.7%  
Price / Book Value ratio x4.35.3 80.8%  
Dividend payout %26.031.4 82.8%   
Avg Mkt Cap Rs m261,879365,592 71.6%   
No. of employees `00014.311.8 121.0%   
Total wages/salary Rs m15,0555,423 277.6%   
Avg. sales/employee Rs Th5,822.64,175.1 139.5%   
Avg. wages/employee Rs Th1,050.5457.7 229.5%   
Avg. net profit/employee Rs Th802.01,141.8 70.2%   
INCOME DATA
Net Sales Rs m83,44449,463 168.7%  
Other income Rs m1,0421,556 67.0%   
Total revenues Rs m84,48651,019 165.6%   
Gross profit Rs m14,73418,718 78.7%  
Depreciation Rs m2,5281,689 149.7%   
Interest Rs m65135 1,858.9%   
Profit before tax Rs m12,59818,551 67.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1055,023 22.0%   
Profit after tax Rs m11,49313,527 85.0%  
Gross profit margin %17.737.8 46.7%  
Effective tax rate %8.827.1 32.4%   
Net profit margin %13.827.3 50.4%  
BALANCE SHEET DATA
Current assets Rs m54,96046,501 118.2%   
Current liabilities Rs m32,4338,468 383.0%   
Net working cap to sales %27.076.9 35.1%  
Current ratio x1.75.5 30.9%  
Inventory Days Days80131 60.8%  
Debtors Days Days7286 84.0%  
Net fixed assets Rs m32,71025,797 126.8%   
Share capital Rs m239531 45.0%   
"Free" reserves Rs m61,36868,962 89.0%   
Net worth Rs m61,60769,493 88.7%   
Long term debt Rs m1,5920-   
Total assets Rs m99,43380,383 123.7%  
Interest coverage x20.4531.0 3.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 136.4%   
Return on assets %12.216.9 72.4%  
Return on equity %18.719.5 95.8%  
Return on capital %21.026.7 78.4%  
Exports to sales %19.10-   
Imports to sales %3.024.6 12.1%   
Exports (fob) Rs m15,917NA-   
Imports (cif) Rs m2,48312,187 20.4%   
Fx inflow Rs m16,06141,238 38.9%   
Fx outflow Rs m2,48312,405 20.0%   
Net fx Rs m13,57828,833 47.1%   
CASH FLOW
From Operations Rs m5,8519,543 61.3%  
From Investments Rs m-7,414-6,854 108.2%  
From Financial Activity Rs m792-2,459 -32.2%  
Net Cashflow Rs m-731230 -318.4%  

Share Holding

Indian Promoters % 66.9 52.0 128.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 11.8 280.5%  
FIIs % 0.0 19.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 17.2 -  
Shareholders   68,381 31,796 215.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUVEN LIFE SCIENCES  NEULAND LABS  PIRAMAL ENTERPRISES  TTK HEALTHCARE  SHASUN PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Momentum Moves: The Week Gone By(Momentum Moves)

Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 4.9% YoY). Sales on the other hand came in at Rs 14 bn (up 3.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 15, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - GSK PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS